Doctors test if less medication can prevent deadly transplant complication
NCT ID NCT05238155
Summary
This study looked at whether giving liver transplant patients a lower dose of anti-rejection drugs could help prevent a rare but deadly complication called graft-versus-host disease (GVHD). Researchers followed 100 adult transplant recipients for a year to see if this approach reduced GVHD without increasing the risk of the body rejecting the new liver. The goal was to find a safer balance in long-term medication management after transplant.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GRAFT VS HOST DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Methodist Dallas Medical Center
Dallas, Texas, 75203, United States
Conditions
Explore the condition pages connected to this study.